ReviewMetabolites2022

Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development.

Kabir Ahluwalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.